Metastatic Pancreas Cancer | NCIC PA.3
A randomised placebo controlled study of OSI-774 (Tarceva™) plus gemcitabine in patients with locally advanced, unresectable or metastatic pancreatic cancer.
Schema
Summary
When cancers of the pancreas are detected they have often spread to other parts of the body (metastases), or they return (recur) after surgery. The best treatment in this situation is chemotherapy with a drug called gemcitabine. As a result of chemotherapy, in many cases, the cancer will stop growing or get smaller for a time. In spite of chemotherapy, many of the cancers will start growing or return after a period of time. This trial will determine if a new drug, OSI-774 (Tarceva™) given with chemotherapy will result in people living longer and with better quality of life.
